Fusobacterium nucleatum caused drug-resistant around
tumor sites often leads to the failure of
chemotherapy during
colorectal cancer (CRC) treatment. Multifunctional cationic quaternary
ammonium materials have been widely used as broad-spectrum
antibacterial agents in antibacterial and anticancer fields. Herein, we design a smart supramolecular quaternary
ammonium nanoparticle, namely quaternary
ammonium PAMAM-AZO@CP[5]A (Q-P-A@CP[5]A), consisting of
azobenzene (AZO)-conjugated dendritic cationic quaternary
ammonium polyamidoamine (PAMAM) as the core and
carboxylatopillar[5]arene (CP[5]A)-based switch, for antibacterial and anti-CRC
therapies. The quaternary
ammonium-PAMAM-AZO (Q-P-A) core endows the supramolecular system with enhanced antibacterial and anticancer properties. -N+CH3 groups on the surface of Q-P-A are accommodated in the CP[5]A cavity under normal conditions, which significantly improves the biocompatibility of Q-P-A@CP[5]A. Meanwhile, the CP[5]A host can be detached from -N+CH3 groups under pathological conditions, achieving efficient antibacterial and antitumor
therapies. Furthermore,
azoreductase in the
tumor site can break the -NN- bonds of AZO in Q-P-A@CP[5]A, leading to the morphology recovery of supramolecular nanoparticles and CRC
therapy through inducing cell membrane
rupture. Both in vitro and in vivo experiments demonstrate that Q-P-A@CP[5]A possesses good biocompatibility, excellent antibacterial effect, and CRC treatment capability with negligible side effects. This supramolecular quaternary
ammonium system provides an effective treatment method to overcome
chemotherapy-resistant
cancer caused by bacteria.